Carregant...
Extreme caution on the use of sirolimus for the congenital hyperinsulinism in infancy patient
We have recently published on the limited effectiveness of sirolimus as a treatment option for hypoglycaemia as a consequence of hyperinsulinism. Our data oppose the view that mTOR inhibitors provide new opportunities for the treatment of patients with hyperinsulinism. We are not convinced by the ar...
Guardat en:
| Publicat a: | Orphanet J Rare Dis |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5391606/ https://ncbi.nlm.nih.gov/pubmed/28410602 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-017-0621-5 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|